|
US226A
(en)
|
|
1837-06-03 |
|
Samuel goss |
|
US541606A
(en)
|
|
1895-06-25 |
|
Sealed package |
|
US7709A
(en)
|
|
1850-10-08 |
Chas S Gaylord |
Improved spring-grapple
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
WO1988001649A1
(en)
|
1986-09-02 |
1988-03-10 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5869620A
(en)
|
1986-09-02 |
1999-02-09 |
Enzon, Inc. |
Multivalent antigen-binding proteins
|
|
US5606040A
(en)
|
1987-10-30 |
1997-02-25 |
American Cyanamid Company |
Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group
|
|
US5770701A
(en)
|
1987-10-30 |
1998-06-23 |
American Cyanamid Company |
Process for preparing targeted forms of methyltrithio antitumor agents
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
|
AU675916B2
(en)
|
1991-06-14 |
1997-02-27 |
Genentech Inc. |
Method for making humanized antibodies
|
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
|
ATE274055T1
(de)
|
1991-10-25 |
2004-09-15 |
Immunex Corp |
Neue cytokine
|
|
US5474771A
(en)
|
1991-11-15 |
1995-12-12 |
The Trustees Of Columbia University In The City Of New York |
Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same
|
|
US5932448A
(en)
|
1991-11-29 |
1999-08-03 |
Protein Design Labs., Inc. |
Bispecific antibody heterodimers
|
|
ATE408012T1
(de)
|
1991-12-02 |
2008-09-15 |
Medical Res Council |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
|
WO1994010308A1
(en)
|
1992-10-23 |
1994-05-11 |
Immunex Corporation |
Methods of preparing soluble, oligomeric proteins
|
|
WO1994011026A2
(en)
|
1992-11-13 |
1994-05-26 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
|
|
US5635483A
(en)
|
1992-12-03 |
1997-06-03 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Tumor inhibiting tetrapeptide bearing modified phenethyl amides
|
|
DE69329974T2
(de)
|
1992-12-04 |
2001-07-19 |
Medical Research Council, London |
Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
|
|
US5780588A
(en)
|
1993-01-26 |
1998-07-14 |
Arizona Board Of Regents |
Elucidation and synthesis of selected pentapeptides
|
|
EP0721346B1
(en)
|
1993-09-02 |
1998-06-10 |
Trustees of Dartmouth College |
Methods for inducing antigen-specific t cell tolerance
|
|
IL110852A
(en)
|
1993-09-02 |
1999-05-09 |
Dartmouth College |
Methods of prolonged suppression of humoral activity
|
|
WO1995015388A1
(en)
|
1993-12-03 |
1995-06-08 |
Medical Research Council |
Recombinant binding proteins and peptides
|
|
US5773001A
(en)
|
1994-06-03 |
1998-06-30 |
American Cyanamid Company |
Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
AUPO591797A0
(en)
|
1997-03-27 |
1997-04-24 |
Commonwealth Scientific And Industrial Research Organisation |
High avidity polyvalent and polyspecific reagents
|
|
US5712374A
(en)
|
1995-06-07 |
1998-01-27 |
American Cyanamid Company |
Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
|
|
DE69631331T2
(de)
|
1995-06-07 |
2004-11-18 |
Immunex Corp., Seattle |
Cd40l mutein
|
|
US5714586A
(en)
|
1995-06-07 |
1998-02-03 |
American Cyanamid Company |
Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
|
|
US5989830A
(en)
|
1995-10-16 |
1999-11-23 |
Unilever Patent Holdings Bv |
Bifunctional or bivalent antibody fragment analogue
|
|
US6001358A
(en)
|
1995-11-07 |
1999-12-14 |
Idec Pharmaceuticals Corporation |
Humanized antibodies to human gp39, compositions containing thereof
|
|
US6440418B1
(en)
|
1995-11-07 |
2002-08-27 |
Idec Pharmaceuticals Corporation |
Methods of treating autoimmune diseases with gp39-specific antibodies
|
|
NL1003537C2
(nl)
|
1996-07-08 |
1998-01-12 |
Holland Railconsult B V |
Werkwijze voor het vervaardigen van een gebogen beglazing.
|
|
JP2002500648A
(ja)
|
1997-05-17 |
2002-01-08 |
バイオジェン インコーポレイテッド |
反適応性の免疫応答、特に移植片拒絶を防ぐためのｃｄ４０：ｃｄ１５４結合妨害剤の使用
|
|
DE69833755T2
(de)
|
1997-05-21 |
2006-12-28 |
Biovation Ltd. |
Verfahren zur herstellung von nicht-immunogenen proteinen
|
|
WO1999051258A1
(en)
|
1998-04-03 |
1999-10-14 |
Trustees Of Dartmouth College |
USE OF ANTI-gp39 ANTIBODIES FOR TREATMENT AND/OR REVERSAL OF LUPUS AND ASSOCIATED KIDNEY DISEASE
|
|
DE19819846B4
(de)
|
1998-05-05 |
2016-11-24 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Multivalente Antikörper-Konstrukte
|
|
US6818749B1
(en)
|
1998-10-31 |
2004-11-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Variants of humanized anti carcinoma monoclonal antibody cc49
|
|
GB9915653D0
(en)
|
1999-07-06 |
1999-09-01 |
Bruce Terry |
Hose clamp
|
|
WO2001024823A1
(en)
|
1999-10-04 |
2001-04-12 |
Chiron Corporation |
Cd40 antagonist for treating psoriasis
|
|
EP1242438B1
(en)
|
1999-12-29 |
2006-11-08 |
Immunogen, Inc. |
Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use
|
|
US20030103978A1
(en)
|
2000-02-23 |
2003-06-05 |
Amgen Inc. |
Selective binding agents of osteoprotegerin binding protein
|
|
GB0006398D0
(en)
|
2000-03-16 |
2000-05-03 |
Novartis Ag |
Organic compounds
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US7041870B2
(en)
|
2000-11-30 |
2006-05-09 |
Medarex, Inc. |
Transgenic transchromosomal rodents for making human antibodies
|
|
EP2298809A3
(en)
|
2001-07-12 |
2012-02-15 |
FOOTE, Jefferson |
Super humanized antibodies
|
|
US6833441B2
(en)
|
2001-08-01 |
2004-12-21 |
Abmaxis, Inc. |
Compositions and methods for generating chimeric heteromultimers
|
|
US7495090B2
(en)
|
2002-05-23 |
2009-02-24 |
The Regents Of The University Of California |
Nucleic acids encoding chimeric CD154 polypeptides
|
|
JP4794301B2
(ja)
|
2003-06-11 |
2011-10-19 |
中外製薬株式会社 |
抗体の製造方法
|
|
KR20120090094A
(ko)
|
2003-06-13 |
2012-08-16 |
바이오겐 아이덱 엠에이 인코포레이티드 |
아글리코실 항-ｃｄ154(ｃｄ40 리간드) 항체 및 이의 용도
|
|
DK1725249T3
(en)
|
2003-11-06 |
2014-03-17 |
Seattle Genetics Inc |
Monomethylvaline compounds capable of conjugating to ligands.
|
|
EA014226B1
(ru)
|
2004-07-26 |
2010-10-29 |
Байоджен Айдек Ма Инк. |
Антитела к cd154, их фрагменты и способы применения антител и фрагментов
|
|
US7563443B2
(en)
|
2004-09-17 |
2009-07-21 |
Domantis Limited |
Monovalent anti-CD40L antibody polypeptides and compositions thereof
|
|
US7566772B2
(en)
|
2005-01-26 |
2009-07-28 |
Amgen Fremont Inc. |
Antibodies against interleukin-1β
|
|
KR101374454B1
(ko)
|
2005-03-31 |
2014-03-17 |
추가이 세이야쿠 가부시키가이샤 |
회합제어에 의한 폴리펩티드 제조방법
|
|
WO2006125201A2
(en)
|
2005-05-19 |
2006-11-23 |
Centocor, Inc. |
Anti-biotin-pegylated-mcp-1 mutein antibodies, compositions, methods and uses
|
|
US8114964B2
(en)
|
2005-05-19 |
2012-02-14 |
Centocor, Inc. |
Anti-MCP-1 antibodies, compositions, methods and uses
|
|
US8871912B2
(en)
|
2006-03-24 |
2014-10-28 |
Merck Patent Gmbh |
Engineered heterodimeric protein domains
|
|
JP2009541275A
(ja)
|
2006-06-22 |
2009-11-26 |
ノボ・ノルデイスク・エー／エス |
二重特異性抗体の生産
|
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
|
JP5258119B2
(ja)
|
2006-11-20 |
2013-08-07 |
ナノステラー インコーポレイテッド |
金属ナノ粒子を含む不均一系触媒を製造するための方法
|
|
PL2125894T3
(pl)
|
2007-03-22 |
2019-08-30 |
Biogen Ma Inc. |
Białka wiążące, w tym przeciwciała, pochodne przeciwciał i fragmenty przeciwciał, które swoiście wiążą się z CD154 i ich zastosowania
|
|
CN101802015B
(zh)
|
2007-03-29 |
2015-05-06 |
根马布股份公司 |
双特异性抗体及其制造方法
|
|
US8748356B2
(en)
|
2007-10-19 |
2014-06-10 |
Janssen Biotech, Inc. |
Methods for use in human-adapting monoclonal antibodies
|
|
CA2710373A1
(en)
|
2007-12-19 |
2009-07-09 |
Ping Tsui |
Design and generation of human de novo pix phage display libraries via fusion to pix or pvii, vectors, antibodies and methods
|
|
AU2009204501B2
(en)
|
2008-01-07 |
2015-02-12 |
Amgen Inc. |
Method for making antibody Fc-heterodimeric molecules using electrostatic steering effects
|
|
NZ588554A
(en)
|
2008-04-29 |
2013-03-28 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
US20100261620A1
(en)
|
2008-10-14 |
2010-10-14 |
Juan Carlos Almagro |
Methods of Humanizing and Affinity-Maturing Antibodies
|
|
CA2759233C
(en)
|
2009-04-27 |
2019-07-16 |
Oncomed Pharmaceuticals, Inc. |
Method for making heteromultimeric molecules
|
|
GB201005063D0
(en)
|
2010-03-25 |
2010-05-12 |
Ucb Pharma Sa |
Biological products
|
|
EP3141260B1
(en)
|
2009-11-30 |
2019-08-14 |
Janssen Biotech, Inc. |
Antibody fc mutants with ablated effector functions
|
|
US20110206672A1
(en)
|
2010-02-25 |
2011-08-25 |
Melvyn Little |
Antigen-Binding Molecule And Uses Thereof
|
|
PL2560993T3
(pl)
|
2010-04-20 |
2024-11-04 |
Genmab A/S |
Heterodimeryczne białka zawierające region FC przeciwciała i sposoby ich wytwarzania
|
|
EP2569337A1
(en)
|
2010-05-14 |
2013-03-20 |
Rinat Neuroscience Corp. |
Heterodimeric proteins and methods for producing and purifying them
|
|
US8795950B2
(en)
|
2010-06-30 |
2014-08-05 |
Jonghan Choi |
Method of improving print performance in flexographic printing plates
|
|
EP2420253A1
(en)
|
2010-08-20 |
2012-02-22 |
Leadartis, S.L. |
Engineering multifunctional and multivalent molecules with collagen XV trimerization domain
|
|
EP2444101A1
(en)
|
2010-10-21 |
2012-04-25 |
Universitätsklinikum Freiburg |
Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis
|
|
US20140121123A1
(en)
*
|
2010-10-29 |
2014-05-01 |
Kevin Caili Wang |
Methods for diversifying antibodies, antibodies derived therefrom and uses thereof
|
|
AU2011325833C1
(en)
|
2010-11-05 |
2017-07-13 |
Zymeworks Bc Inc. |
Stable heterodimeric antibody design with mutations in the Fc domain
|
|
HUE033205T2
(en)
|
2010-12-23 |
2017-11-28 |
Janssen Biotech Inc |
Active protease-resistant antibody fc mutants
|
|
AU2012223358A1
(en)
|
2011-03-01 |
2013-09-05 |
Amgen Inc. |
Sclerostin and DKK-1 bispecific binding agents
|
|
CA2832281C
(en)
|
2011-04-04 |
2019-11-05 |
Trustees Of Dartmouth College |
Anti-cd154 antibodies having impaired fcr binding and/or complement binding properties and the use thereof in immune therapies
|
|
DK2771022T3
(da)
|
2011-10-11 |
2020-09-28 |
Viela Bio Inc |
Cd40l-specifikke tn3-afledte skeletter (scaffolds) og fremgangsmåder til anvendelse deraf
|
|
SMT202000091T1
(it)
|
2011-10-13 |
2020-05-08 |
Bristol Myers Squibb Co |
Polipeptidi anticorpali che antagonizzano cd40l
|
|
AU2013267161A1
(en)
|
2012-05-31 |
2014-11-20 |
Sorrento Therapeutics, Inc. |
Antigen binding proteins that bind PD-L1
|
|
CN110042105B
(zh)
|
2012-12-14 |
2023-03-28 |
欧莫诺艾比公司 |
编码具有人独特型的啮齿动物抗体的多核苷酸以及包含所述多核苷酸的动物
|
|
CN107921128B
(zh)
*
|
2015-08-05 |
2022-04-26 |
詹森生物科技公司 |
抗cd154抗体及其使用方法
|
|
US10651781B2
(en)
|
2017-08-24 |
2020-05-12 |
Corning Incorporated |
Glass roof shingle
|